Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 56 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 9877990

    Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

    Krystal Biotech, Inc. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  2. US 9878993

    DNA-PK inhibitors for treatment of cancer

    Vertex Pharmaceuticals Incorporated · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  3. US 9878033

    Immunogenic peptides for treatment of herpes simplex virus infection and conditions

    The Regents of the University of California · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  4. US 9878006

    Treatment of obesity and obesity related disorders by pharmalogical targeting of Kv1.3 potassium channels

    The Regents of the University of California · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  5. US 9873876

    Cancer treatment

    Ionis Pharmaceuticals, Inc. · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted

  6. US 9872909

    Method for enhancing specific immunotherapies in cancer treatment

    Providence Health & Services—Oregon · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted

  7. US 9868954

    Reduction of TGFβ signaling in myeloid cells in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  8. US 9867778

    Controlled release antimicrobial compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  9. US 9867830

    Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  10. US 9868725

    Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's disease

    Takeda Pharmaceutical Company Limited · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  11. US 9861621

    LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

    Biomed Valley Discoveries, Inc. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  12. US 9861600

    Methods and compositions for treating and identifying compounds to treat age-related macular degeneration treatment

    Arizona Board of Regents, A Body Corporate Of The State Of Arizona Acting For An On Behalf Of The University of Arizona · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  13. US 2018000900

    COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

    GANYMED PHARMACEUTICALS AG [DE] · Granted Jan 4, 2018 · Expires Dec 30, 2037

    granted

  14. US 9855312

    GHRH agonists for the treatment of ischemic disorders

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  15. US 9855226

    d-methadone for the treatment of psychiatric symptoms

    Relmada Therapeutics, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  16. US 9855241

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  17. US 9855249

    Isoxazole compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  18. US 9856453

    Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  19. US 9844530

    Ophthalmic solutions for glaucoma and conjunctivitis treatment

    AXIM BIOTECHNOLOGIES. INC. · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted

  20. US 9844568

    Porous carbon particles for use in the treatment or prevention of liver disease

    University of Brighton · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted

  21. US 9840536

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted

  22. US 9839688

    Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer

    Provectus Pharmatech, Inc. · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted

  23. US 9833498

    Methods of treatment of collagen-mediated diseases and conditions

    HALOZYME, INC. · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  24. US 9833450

    Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders

    Lixte Biotechnology, Inc. · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.